Sunrest Lifescience Ltd
Ticker: SUNREST
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
45.50
Market Cap
20.22
Debt/Equity
0.3813
ROE %
13.109
PB
1.2496
Promoter %
53.505
Pledge %
0.000
1Y Rev Growth %
12.347
5Y Rev Growth %
24.777
NP Margin %
6.008
NP Margin 5Y Avg %
3.805
Trading Reference
1M Return %
-2.151
6M Return %
-9.000
1Y Return %
-21.552
% Away 52W High
64.835
% Away 52W Low
13.325
Daily Volume
1600
Investment Verdict
Buy
Score 79/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 20/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
More Options
P
Polo Hotels Ltd
Polo Hotels Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation ratios. Caution is advised for potential investors.
View details
N
Nippon India ETF Nifty India Consumption
The ETF is positioned well in a growing sector, but faces challenges in execution and valuation metrics.
View details
G
Gujarat Raffia Industries Ltd
Gujarat Raffia Industries Ltd shows moderate potential but faces challenges in growth and profitability metrics.
View details
V
Valson Industries Ltd
Valson Industries Ltd shows some potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
B
Brisk Technovision Ltd
Brisk Technovision Ltd shows potential in a future-ready sector but faces significant challenges in growth consistency and profitability, making it a risky investment.
View details
S
Supra Trends Ltd
Supra Trends Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
RAP Corp Ltd
RAP Corp Ltd shows potential but faces significant risks and challenges that may hinder growth and profitability.
View details
D
DSP Silver ETF
The DSP Silver ETF presents a decent investment opportunity with potential for growth, but investors should be cautious of market volatility and price fluctuations in silver.
View details
H
Helpage Finlease Ltd
Helpage Finlease Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and profitability, making it a risky investment at this time.
View details
S
SVS Ventures Ltd
SVS Ventures Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Z
Zenlabs Ethica Ltd
Zenlabs Ethica Ltd shows potential but faces significant challenges in growth and profitability, making it a risky investment.
View details
E
EP Biocomposites Ltd
EP Biocomposites Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics. Caution is advised for investors.
View details
S
Stampede Capital Ltd
Stampede Capital Ltd shows potential but faces significant risks that could impact future performance.
View details
M
Marinetrans India Ltd
Marinetrans India Ltd shows some potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
View details
R
Rita Finance and Leasing Ltd
Rita Finance and Leasing Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Ishan International Ltd
Ishan International Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Sunrest Lifescience Ltd is a leading player in the Indian pharmaceutical sector, dedicated to enhancing healthcare through innovative solutions. Catering to a diverse clientele, including hospitals, clinics, and pharmacies, the company focuses on delivering high-quality medicines and healthcare products. With a commitment to research and development, Sunrest Lifescience is at the forefront of addressing critical health challenges. Its robust distribution network ensures accessibility across the country, making it a trusted partner in health and wellness.
- Established leader in the Indian pharmaceutical market
- Focus on innovative healthcare solutions
- Wide range of high-quality medicines
- Strong commitment to research and development
- Extensive distribution network across India
- Trusted partner for healthcare providers
Investment Thesis
Sunrest Lifescience Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic positioning make it a valuable addition to any portfolio.
- Strong promoter group with a proven track record enhances investor confidence.
- Digital services segment poised for substantial growth, tapping into evolving market trends.
- Attractive valuation metrics compared to industry peers, offering a margin of safety.
- Focus on innovation and quality positions the company well for future expansion.
- Solid financial performance and growth outlook make it a promising investment.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong R&D pipeline
- Strategic partnerships with key players
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the sector
- Supply chain disruptions
- Dependence on key personnel
Peer Perspective
Sunrest Lifescience Ltd trades at a significant discount compared to peers like Dr. Reddy's and Cipla, primarily due to margin volatility. A consistent improvement in margins could trigger a rerating in the stock.
Future Outlook
Sunrest Lifescience Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market opportunities, provided they maintain strong execution and effective cost control measures.
AI FAQs for Retail Users
- Q: What does Sunrest Lifescience Ltd do?A: Sunrest Lifescience Ltd focuses on manufacturing and distributing pharmaceutical and healthcare products.
- Q: Is Sunrest Lifescience Ltd a good investment?A: Investing depends on individual financial goals; consider researching the company and market trends.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, regulatory changes, and company-specific performance factors.
- Q: How can I buy shares of Sunrest Lifescience Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What is the company's growth potential?A: Growth potential can vary; it's important to analyze industry trends and company performance.
📊 Stock Investment Checklist (100 Points)
Sunrest Lifescience Ltd • Updated: 2025-09-17 17:08:19
-
10BusinessHighThe sector shows potential due to increasing demand for healthcare products, but the company's competitive edge is unclear.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
8ProfitabilityHighROE and ROCE are below industry averages, and cash flow is not stable.
-
9ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but there are some concerns regarding transparency.
-
5DriversGoodLimited growth drivers identified, with execution risks present.
-
1TechnicalsLowMarket sentiment is weak, with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
Sunrest Lifescience Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100